Abeona Therapeutics, Inc. (ABEO)
5.85
-0.07
(-1.18%)
USD |
NASDAQ |
Aug 31, 16:00
5.86
+0.01
(+0.17%)
After-Hours: 20:00
Abeona Therapeutics Cash from Operations (Annual) : -76.33M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -76.33M |
| December 31, 2024 | -56.02M |
| December 31, 2023 | -37.16M |
| December 31, 2022 | -43.48M |
| December 31, 2021 | -65.66M |
| December 31, 2020 | -35.02M |
| December 31, 2019 | -62.82M |
| December 31, 2018 | -39.11M |
| December 31, 2017 | -22.94M |
| December 31, 2016 | -13.01M |
| December 31, 2015 | -10.42M |
| December 31, 2014 | -1.611M |
| December 31, 2013 | 0.001M |
| December 31, 2012 | -3.955M |
| Date | Value |
|---|---|
| December 31, 2011 | -7.609M |
| December 31, 2010 | -6.86M |
| December 31, 2009 | -2.248M |
| December 31, 2008 | -6.56M |
| December 31, 2007 | -4.843M |
| December 31, 2006 | -1.958M |
| December 31, 2005 | -7.301M |
| December 31, 2004 | -8.411M |
| December 31, 2003 | -6.363M |
| December 31, 2002 | -8.595M |
| December 31, 2001 | -5.272M |
| December 31, 2000 | -4.331M |
| December 31, 1999 | -3.245M |
| December 31, 1998 | -3.239M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Forum Markets, Inc. | -26.05M |
| Corcept Therapeutics, Inc. | 142.00M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| Alnylam Pharmaceuticals, Inc. | 524.08M |
| Anika Therapeutics, Inc. | 11.19M |